A Phase II Study of S-1 (S) Plus Cisplatin (P) with Concurrent Thoracic Radiotherapy (TRT) for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC) West Japan Oncology Group (WJOG) 3706 Trial

被引：0

作者：

Katakami, Nobuyuki

Kokubo, Masaki

Sawa, Toshiyuki ^{[1
]}

Tanaka, Masahiro ^{[2
]}

Seto, Takashi ^{[3
]}

Sasaki, Tomonari ^{[4
]}

Yamanaka, Takeharu ^{[5
]}

Ichinose, Yukito ^{[3
]}

Nishimura, Yasumasa ^{[6
]}

Nakagawa, Kazuhiko ^{[7
]}

机构：

[1] Gifu City Hosp, Dept Pulm Med, Gifu, Japan

[2] Osaka City Gen Hosp, Dept Clin Oncol, Osaka, Japan

[3] Kyushu Natl Canc Ctr, Dept Thorac Oncol, Fukuoka, Japan

[4] Kumamoto Univ, Sch Med, Dept Pulm Med, Kumamoto 860, Japan

[5] Kyushu Natl Canc Ctr, Dept Clin Trial, Fukuoka, Japan

[6] Kinki Univ, Sch Med, Dept Radiat Oncol, Higashiosaka, Osaka 577, Japan

[7] Kinki Univ, Sch Med, Dept Med Oncol, Higashiosaka, Osaka 577, Japan

来源：

JOURNAL OF THORACIC ONCOLOGY | 2010年 / 5卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S372 / S372

页数：1

共 50 条

[31] Carboplatin, S-1 and concurrent thoracic radiotherapy for elderly patients with locally advanced non-small cell lung cancer: a multicenter Phase I/II study
Niho, Seiji
Hosomi, Yukio
Okamoto, Hiroaki
Nihei, Keiji
Tanaka, Hiroshi
Hida, Toyoaki
Umemura, Shigeki
Goto, Koichi
Akimoto, Tetsuo
Ohe, Yuichiro
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (07) : 614 - 619
[32] Phase II study of cisplatin plus etoposide with concurrent thoracic radiotherapy (TRT) followed by irinotecan plus cisplatin in limited stage small-cell lung cancer (SCLC); A West Japan Thoracic Cincology Group Trial
Kashii, T
Saito, H
Negoro, S
Takada, Y
Ichinose, Y
Matsui, K
Eguchi, K
Tamura, K
Ariyoshi, Y
Fukuoka, M
LUNG CANCER, 2005, 49 : S322 - S322
[33] Phase II study of irinotecan and S-1 combination therapy in patients (pts) with advanced non-small cell lung cancer (NSCLC): results of West Japan Thoracic Oncology Group trial (WJTOG3505)
Yoshioka, Hiroshige
Okamoto, Isamu
Kubo, Akihito
Takeda, Koji
Sugawara, Shunichi
Katakami, Nobuyuki
Tsuboi, Masahiro
Nishimura, Takashi
Fukuoka, Masahiro
JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S451 - S451
[34] Long-term results of S-1 plus cisplatin with concurrent thoracic radiotherapy for locally advanced non-small-cell lung cancer
Tetsuhiko Taira
Kiyotaka Yoh
Seisuke Nagase
Kaoru Kubota
Hironobu Ohmatsu
Seiji Niho
Masakatsu Onozawa
Tetsuo Akimoto
Yuichiro Ohe
Koichi Goto
Cancer Chemotherapy and Pharmacology, 2018, 81 : 565 - 572
[35] Long-term results of S-1 plus cisplatin with concurrent thoracic radiotherapy for locally advanced non-small-cell lung cancer
Taira, Tetsuhiko
Yoh, Kiyotaka
Nagase, Seisuke
Kubota, Kaoru
Ohmatsu, Hironobu
Niho, Seiji
Onozawa, Masakatsu
Akimoto, Tetsuo
Ohe, Yuichiro
Goto, Koichi
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (03) : 565 - 572
[36] A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study): primary analysis
Tanaka, Hisashi
Tanzawa, Shigeru
Misumi, Toshihiro
Makiguchi, Tomonori
Inaba, Megumi
Honda, Takeshi
Nakamura, Junya
Inoue, Koji
Kishikawa, Takayuki
Nakashima, Masanao
Fujiwara, Keiichi
Kohyama, Tadashi
Ishida, Hiroo
Kuyama, Shoichi
Miyazawa, Naoki
Nakamura, Tomomi
Miyawaki, Hiroshi
Oda, Naohiro
Ishikawa, Nobuhisa
Morinaga, Ryotaro
Kusaka, Kei
Fujimoto, Nobukazu
Fukuda, Yasushi
Yasugi, Masayuki
Tsuda, Takeshi
Ushijima, Sunao
Shibata, Kazuhiko
Shibayama, Takuo
Bessho, Akihiro
Kaira, Kyoichi
Shiraishi, Kenshiro
Matsutani, Noriyuki
Seki, Nobuhiko
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
[37] A phase II study of S-1 chemotherapy with concurrent thoracic radiotherapy in elderly patients with locally advanced non-small-cell lung cancer: The Okayama Lung Cancer Study Group Trial 0801
Aoe, Keisuke
Takigawa, Nagio
Hotta, Katsuyuki
Maeda, Tadashi
Kishino, Daizo
Nogami, Naoyuki
Tabata, Masahiro
Harita, Shingo
Okada, Toshiaki
Kubo, Toshio
Hosokawa, Shinobu
Fujiwara, Keiichi
Gemba, Kenichi
Yasugi, Masayuki
Kozuki, Toshiyuki
Kato, Yuka
Katsui, Kuniaki
Kanazawa, Susumu
Ueoka, Hiroshi
Tanimoto, Mitsune
Kiura, Katsuyuki
EUROPEAN JOURNAL OF CANCER, 2014, 50 (16) : 2783 - 2790
[38] Randomized phase II trial of S-1 plus cisplatin or docetaxel plus cisplatin with concurrent thoracic radiotherapy for inoperable stage III non-small cell lung cancer (TORG1018).
Kubota, Kaoru
Shimokawa, Tsuneo
Yamada, Kazuhiko
Tanaka, Hiroshi
Kishi, Kazuma
Saito, Haruhiro
Takiguchi, Yuichi
Hosomi, Yukio
Kato, Terufumi
Nogami, Naoyuki
Yamanaka, Takeharu
Masuda, Noriyuki
Watanabe, Koshiro
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[39] A phase I study of S-1 with concurrent radiotherapy in elderly patients with locally advanced non-small cell lung cancer
Yoshikazu Hasegawa
Isamu Okamoto
Ken Takezawa
Masaaki Miyazaki
Junji Tsurutani
Kimio Yonesaka
Ryotaroh Morinaga
Asuka Tsuya
Masaaki Terashima
Toshihiro Kudoh
Koichi Azuma
Takayasu Kurata
Tatsuyuki Nishikawa
Masahiro Fukuoka
Yasumasa Nishimura
Kazuhiko Nakagawa
Investigational New Drugs, 2013, 31 : 599 - 604
[40] A phase I study of S-1 with concurrent radiotherapy in elderly patients with locally advanced non-small cell lung cancer
Hasegawa, Yoshikazu
Okamoto, Isamu
Takezawa, Ken
Miyazaki, Masaaki
Tsurutani, Junji
Yonesaka, Kimio
Morinaga, Ryotaroh
Tsuya, Asuka
Terashima, Masaaki
Kudoh, Toshihiro
Azuma, Koichi
Kurata, Takayasu
Nishikawa, Tatsuyuki
Fukuoka, Masahiro
Nishimura, Yasumasa
Nakagawa, Kazuhiko
INVESTIGATIONAL NEW DRUGS, 2013, 31 (03) : 599 - 604

← 1 2 3 4 5 →